PerpEquities

Laporan laba rugi Kodiak Sciences Inc. (KOD)

NASDAQ · Healthcare · Biotechnology · Karyawan: 141 · CEO: Victor Perlroth

Harga
$99,18 -1,22%
Kapitalisasi pasar
$6,23 M
Nilai perusahaan
$6,2 M
Laporan terakhir
Q2 '26 diajukan 2026-08-13
Laporan berikutnya
2026-11-12 Estimasi EPS: -$1,06

Laporan laba rugi

Laporan laba rugiTrenQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Beban pokok pendapatan$6,97 jt$6,66 jt$6,65 jt$6,68 jt$6,7 jt$6,68 jt$0$0$0$0$0$0
Laba kotor-$6,97 jt-$6,66 jt-$6,65 jt-$6,68 jt-$6,7 jt-$6,68 jt$0$0$0$0$0$0
Riset & pengembangan$36,2 jt$46,6 jt$29,9 jt$32,5 jt$31,9 jt$31,8 jt$43,6 jt$42,8 jt$50,5 jt$45,5 jt$48,5 jt$56,1 jt
Penjualan & pemasaran$0-$6,66 jt$0$0$0$0$0$0$0$0$0$0
Umum & administrasi$0$16,7 jt$0$0$0$0$13,5 jt$12,8 jt$11,9 jt$12 jt$11,2 jt$10,8 jt
Beban operasional lainnya$0$0$0$0$0$0$1,91 jt$0$0$0$0$0
Beban operasional$47,5 jt$56,7 jt$39,4 jt$41,3 jt$39,9 jt$39,5 jt$59,1 jt$55,5 jt$62,4 jt$57,5 jt$59,8 jt$66,8 jt
Laba operasional-$54,5 jt-$63,4 jt-$46,1 jt-$48 jt-$46,6 jt-$46,2 jt-$59,1 jt-$55,5 jt-$62,4 jt-$57,5 jt-$59,8 jt-$66,8 jt
Pendapatan bunga$4,54 jt$3,9 jt$3,35 jt$2,95 jt$2,71 jt$2,13 jt$1,6 jt$1,24 jt$917 rb$757 rb$1,64 jt$1,26 jt
Beban bunga$5 rb$0$0$0$0$0$0$0$0$0$0$0
Pendapatan non-operasional lainnya (keuntungan investasi, kurs ...)-$4,5 jt-$3,86 jt-$3,02 jt-$2,87 jt-$2,69 jt-$2,07 jt-$1,61 jt-$1,2 jt-$895 rb-$4,42 jt-$1,62 jt-$60 rb
Total pendapatan non-operasional$4,49 jt$3,86 jt$3,02 jt$2,87 jt$2,69 jt$2,07 jt$1,61 jt$1,2 jt$895 rb$717 rb$1,62 jt$1,2 jt
Laba sebelum pajak-$50 jt-$59,5 jt-$43 jt-$45,1 jt-$43,9 jt-$44,1 jt-$57,5 jt-$54,3 jt-$61,5 jt-$56,7 jt-$58,2 jt-$65,6 jt
Laba bersih-$50 jt-$59,5 jt-$43 jt-$45,1 jt-$43,9 jt-$44,1 jt-$57,5 jt-$54,3 jt-$61,5 jt-$56,7 jt-$58,2 jt-$65,6 jt
EPS (dasar)-$0,95-$1,13-$0,82-$0,86-$0,84-$0,84-$1,09-$1,03-$1,16-$1,04-$0,94-$1,05
EPS (dilusian)-$0,95-$1,13-$0,82-$0,86-$0,84-$0,84-$1,09-$1,03-$1,16-$1,04-$0,94-$1,05
Saham (dasar, rata-rata tertimbang)52,5 jt52,5 jt52,5 jt52,6 jt52,6 jt52,7 jt52,7 jt52,8 jt52,9 jt53,2 jt61,9 jt62,6 jt
Saham (dilusian, rata-rata tertimbang)52,5 jt52,5 jt52,5 jt52,6 jt52,6 jt52,7 jt52,7 jt52,8 jt52,9 jt53,2 jt61,9 jt62,6 jt
Depresiasi & amortisasi$6,97 jt$6,66 jt$6,65 jt$6,68 jt$6,7 jt$6,68 jt$6,73 jt$6,54 jt$6,54 jt$6,52 jt$6,34 jt$6,19 jt
EBITDA-$43 jt-$52,9 jt-$36,4 jt-$38,4 jt-$37,2 jt-$37,4 jt-$50,7 jt-$47,8 jt-$54,9 jt-$46,5 jt-$51,8 jt-$60,6 jt

Distandardisasi dari laporan perusahaan; arus keluar dan biaya mempertahankan tanda yang dilaporkan penyedia. Arahkan kursor ke periode untuk melihat tanggal berakhirnya. Jumlah dalam USD.

Pendapatan, laba operasional, dan pertumbuhan

kuartalan

Margin

kuartalan

Biaya sebagai % pendapatan

kuartalan

Laporan lainnya

Sumber

Laporan keuangan, pendapatan segmen, metrik, dan estimasi distandardisasi dari laporan perusahaan. Laba segmen dan setiap pos yang dilaporkan: SEC EDGAR (XBRL). Laporan yang dibaca: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

Data per 2026-11-02